KELSEY TEMPLEMAN: Open Payments
NPI 1306307038 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 100 payments from 22 companies in 2025. Trend: 2023 $293 · 2024 $1,832 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $263 |
| Lilly USA, LLC | 12 | $218 |
| Amgen Inc. | 13 | $175 |
| PFIZER INC. | 14 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $98 |
| Novo Nordisk Inc | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lundbeck LLC | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
Products named: MOUNJARO, BREZTRI, REXULTI, OTEZLA, Kerendia, AIRSUPRA, CAPLYTA, EVENITY.
Industry payments across KS — which companies pay providers there.
